Provided by Tiger Trade Technology Pte. Ltd.

Mirum Pharmaceuticals, Inc.

93.60
-5.2200-5.28%
Volume:301.24K
Turnover:28.61M
Market Cap:6.08B
PE:-6.65
High:98.76
Open:98.76
Low:92.51
Close:98.82
52wk High:130.00
52wk Low:63.23
Shares:64.93M
Float Shares:56.42M
Volume Ratio:0.43
T/O Rate:0.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-14.0800
EPS(LYR):-0.4700
ROE:-702.97%
ROA:-6.79%
PB:-583.16
PE(LYR):-199.15

Loading ...

Feb 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 28, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 28, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 28, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 28, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 26, 2026

Major Issues Report

Form 8-K - Current report
Jan 15, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 12, 2026

Major Issues Report

Form 8-K - Current report
Dec 23, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 19, 2025

Major Issues Report

Form 8-K - Current report
Dec 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 19, 2025

Major Issues Report

Form 8-K - Current report
Dec 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 08, 2025

Major Issues Report

Form 8-K - Current report
Dec 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 17, 2025

Major Issues Report

Form 8-K - Current report
Nov 04, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 04, 2025

Major Issues Report

Form 8-K - Current report